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Abstract 
Alzheimer's disease (AD) is a severe neurodegenerative disorder characterized 
by an extracellular deposition of amyloid plaques, and an intraneuronal 
accumulation of neurofibrillary tangles in the brain of affected individuals. A 
42 amino acid long Aβ42 peptide generated by proteolytic processing of the 
APP protein is a major component of the amyloid plaques, in which it is 
mainly represented in the form of detergent-insoluble amyloid fibers. 
Previously, the Aβ42 fibers have been considered to be the major pathogenic 
agents of AD. Thus Small molecules that prevent the formation of Aβ42 
aggregates that lead to the formation of large plaques had previously been of 
interest. Recently, this hypothesis has been challenged by findings suggesting 
that fibrillar aggregates may represent inert dead-end products of the Aβ42 
aggregation pathway. Considerable evidence now suggests that the primary 
neurotoxic effects are associated with soluble SDS-stable assemblies of Aβ42, 
such as 56 kDa Aβ42 dodecamers, or even smaller, low-n (dimers, trimers, and 
tetramers) oligomers of Aβ42, which seem to appear during the early stages of 
Aβ42 assembly, and could give rise to larger oligomers. Thus, the focus of 
putative therapeutic interventions have shifted towards unravelling 
compounds that inhibit the earliest stages of Aβ42 oligomerization. 
In yet another finding, the frequency of [PSI +] induction, the prion of Sup35 
(Yeast Translation Termination Factor) increased with stress. This stress 
related prion induction can be extrapolated to AD using Aβ42-MRF 
oligomerisation model that mimics [PSI +]. 
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Chapter 1 
Introduction 
1.1 Amyloids and Prion diseases 
Proper folding of proteins is essential for proper functioning of 
proteins. A broad range of human diseases arises from the failure 
of a specific peptide or protein to adopt, or remain in, its native 
functional conformational state. These pathological conditions are 
generally referred to as “protein misfolding diseases”. They include 
pathological states in which an impairment in the folding 
efficiency of a given protein results in a reduction in the quantity 
of the protein that is available to play its normal role. This 
reduction can arise as the result of one of several post 
translational processes, such as an increased probability of 
degradation via the quality control system of the endoplasmic 
reticulum, or the improper trafficking of a protein [1]. 
The largest group of misfolding diseases, however, is associated 
with the conversion of specific peptides or proteins from their 
soluble functional states ultimately into highly organized fibrillar 
aggregates. These structures are referred as “amyloid fibrils” 
(Fig.1). When these amyloid fibrils are infectious in nature, they 
are called prions. The word prion is derived from protein and 
infectious. Prions are self-seeding, have high stability and are 
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resistant to protease [1]. Amyloids have cross-β structure where 
the peptide molecules form β-strands perpendicular to the axis of 
the fibril [2]. These fibrils bind specifically to Thioflavin T (ThT) 
dye causing increase in the fluorescence [3] and Congo red (CR) 
dye causing green birefringence when viewed under cross-
polarized light [4].  
 
  
 
 
Fig 1: Formation of amyloid fibrils [5] 
a. Electron microscopy image of Protofibrils 
b. Electron microscopy image of  mature fibrils 
c. Fibrils accumulate as plaques or lewy bodies 
d. Early aggregates in Amorphous structure  
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Misfolding of a protein is the main cause of major 
neurodegenerative diseases like Alzheimer’s, Parkinson’s, 
Amyotrophic Lateral Sclerosis etc [5].  
 
 
 
 
1.2   YEAST: Model for Prion and Amyloid 
diseases 
The yeast Saccharomyces cerevisiae is an ideal in vivo model to 
study human disease mechanism due to conserved basic cellular 
mechanisms, rapid growth on defined media and easy mutant 
isolation [7]. Yeast provides a model system for studying 
Table 1: List of examples of neurodegenerative protein misfolding diseases [6] 
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mechanisms of protein misfolding and aggregation, which is also 
applicable to human diseases [8].  
Yeast has been used as a model system to study the disease 
mechanism of various neurodegenerative diseases like Alzheimer’s 
[9], Parkinson’s [10], and Huntington’s [11] by expression of the 
pathological protein.  
Sup35 protein is involved in the recognition of stop codons in 
yeast. Sup35 N-terminal domain [1-123] is unstructured (Fig.2) 
and is responsible for prion formation, the highly charged, middle 
(M) domain [124-254] promotes the non-prion state. The C-
terminal folded domain [255-685] is responsible for its translation 
termination activity [12].  
 
 
 
 
Fig 2: Domain architecture of Yeast Sup35 Protein [13]. 
 
When the Sup35 is converted from its soluble non-prion state 
[psi–] to its aggregated prion state [PSI+], termination activity of 
the protein is reduced, causing the read-through of stop codons 
[13]. [psi-] cells in ade1–14 background having a premature stop 
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codon, will form red colonies on rich growth medium (YPD) due 
to functional C-terminal region of Sup35MC which would perform 
the translation termination and due to the accumulation of a 
metabolic intermediate of the adenine biosynthesis pathway. If 
the protein is insoluble then it will give white colonies indicative 
of prion formation leading to loss of function of C-terminal of 
Sup35MC and formation of full length Ade1 protein. Sup35 
tagged with GFP is diffuse in [psi-] cells but forms aggregates in 
[PSI+] cells. When total cell lysates (T) are separated into 
supernatant (S) and pellet (P) fractions and Western blots made 
of boiled SDS acrylamide gel separations are developed with 
Sup35 antibody,Sup35 is found largely in the supernatant in [psi-] 
lysates but mostly in the pellet in [PSI+] lysates. When lysates 
are separated on agarose gels, following room temperature 
incubation with 2% SDS, Sup35 runs as a monomer in [psi-] cells 
but mostly as oligomers in the other case [13]. 
 
Fig 3: [PSI+] Phenotypes [13] 
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1.3  Prion Variants 
 
Different heritable states of prions are called as prion variants 
(Fig: 4). Different [PSI+] variants were associated with inherently 
different ratios of aggregated vs. non-aggregated Sup35 protein 
[13]. 
 
 
 
 
 
 
 
 
Fig 4: Differences between weak and strong [PSI+] prion 
variants [13]. 
A. Colony colour difference (red vs pink) 
B. Levels of soluble Sup35 in weak vs. strong [PSI+] strains 
C. Size comparison of SDS resistant Sup35 prion polymers 
D. Cartoon of weak vs. strong [PSI+]  
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1.4 Alzheimer's disease (AD) 
Alzheimer's disease (AD) is a severe neurodegenerative disorder 
characterized by an extracellular deposition of amyloid plaques, 
and an intraneuronal accumulation of neurofibrillary tangles in 
the brain of affected individuals [14]. 
 
 
Fig 5: Hallmark of AD [15] 
 
A 42 amino acid long Aβ42 peptide generated by proteolytic 
processing of the APP (Amyloid Precursor Protein) protein is a 
major component of the amyloid plaques, in which it is mainly 
represented in the form of detergent-insoluble amyloid fibers.The 
Amyloid Precursor Protein is a transmembrane protein. Function 
of this protein is not clear but, when it is cleaved into Aβ peptide, 
the peptide tends to aggregate and form amyloid deposits [14]. 
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1.5 Stress conditions and AD 
Prion switching in response to environmental stress was studied   
which concluded that prion induction increased by as much as 60-
fold when cells were exposed to various stressful conditions, such 
as oxidative stress (H2O2) or high salt concentrations [16]. 
Since the frequency of [PSI +] induction, the prion form of Sup35 
(Yeast Translation Termination Factor) increased with stress. 
This stress related prion induction can be extrapolated to AD 
using yeast Aβ42-MRF oligomerisation model that mimics [PSI +] 
[16]. 
 
1.6 Aβ42-MRF Oligomerisation model 
    Several aggregated forms of the amyloid β peptide (Aβ), which 
are generated by proteolytic processing of the amyloid precursor 
protein (APP), in normal brains and cerebrospinal fluid (CSF) 
are believed to have a crucial role in the development of 
Alzheimer’s disease (AD). Although extracellular amyloid plaques 
and neurofibrillary tangles formed by insoluble fibrils in brains 
are hallmarks of AD, recent findings suggest that smaller non-
fibrillar oligomeric forms of the Aβ peptide are a more likely 
cause of AD.  
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    Indeed, studies in mice as well as mammalian cell culture showed 
that detergent-stable Aβ oligomers are potent neurotoxins. Thus 
the Prevention of formation of Aβ42 fibers that lead to plaque 
deposits was therapeutic area of interest previously. Recently 
focus shifted to earlier stages of Aβ42 oligomerisation [17]. 
Yeast Aβ42-MRF model provides a tool to screen for agents that 
target early stages of Aβ42 oligomerisation. It is an Aβ42 fusion 
to the essential functional domain (MRF) of the translational 
release factor, Sup35 provides an Aβ42 aggregation-specific probe 
tied to a functional Sup35 readout [17]. 
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Chapter 2 
Materials and Methods 
2.1 Yeast strain 
The yeast strain L3149 containing a genomic deletion of SUP35 
(sup35∆::LEU2) was used. The strain was maintained under the 
copper-inducible CUP1 promoter p1364-based URA3 plasmid 
encoding Aβ42-MRF. 
2.2 Yeast culture media 
Standard yeast media YPD was used for reviving yeast strains 
from -80°C. YPD is a non-selective rich media which contains 1% 
Yeast extract, 2% Peptone and 2% Dextrose.  For preparation of 
solid media 2% agar was added. The media was autoclaved for 20 
mins at 121°C. For maintaining the plasmid and for the selection 
of plasmid containing yeast transformants, synthetic “dropout” 
media was used which contains all the nutrients except for uracil.  
The synthetic defined media used were SD-Ura (2% Dextrose). 
2.3 Yeast cultivation 
A single colony of yeast cells were spotted on agar plates, and 
incubated at 30°C for 3 days (complex medium). The desirable 
colour saturation on complex medium was achieved by incubating 
the plates at 4°C for 3 more days.  
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Expression of the Aβ42MRF constructs driven by the copper-
inducible CUP1 promoter was stimulated by the addition of 50 
M CuSO4 to all media. Low concentration of CuSO4 used was 1 
M. 
2.4 Prion induction study with stress conditions 
Stress conditions used were 2mM H2O2, 10mM H2O2, 12mM 
Dithiothreitol (DTT), 1M Ammonium Acetate (NH4Ac). 1 ml of 
YPD broth was inoculated with Aβ42-MRF L3149 strain with the 
stress conditions applied and grown till 0.6 OD600 in rotary shaker 
at 200 rpm at 30°C. One to five fold serial dilutions were 
performed using 100 µl of the culture. 5 µl of the culture was 
spotted in duplicates on YPD and YPD + 1 µM CuSO4 plates 
and was incubated at 30°C, for 2 days YPD.  
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Chapter 3 
Results and Discussion 
3.1 Yeast Growth 
Usually, when Sup35 protein, which is a translation termination 
factor, is over expressed it leads to prion conversion to [PSI+] 
that partially inactivates Sup35 protein thereby allowing read-
through of the premature stop codon in ade1-14 allele. This leads 
to functional ADE1 protein formation that allows for growth on 
media lacking adenine and also, the red intermediate pigment 
does not accumulate hence the [PSI+] yeast is white on YPD-
agar. Thus, this red to white conversion in ade1-14 allele 
containing yeast strain (e.g. 74-D-694) upon over-expression of 
Sup35 protein is scored as de novo [PSI+] prion formation. This 
applies to scoring of Aβ42 amyloid aggregation in strain 
containing Sup35 fusion protein. 
 
 
 
 
 
 
 
 
 
 
      Fig 6: Aβ42-MRF L3149 on                     Fig 7: [PSI -] [PIN -] on 
          SD –URA +1/4 YPD                    SD –URA +1/4 YPD as control. 
 
 
13	
The colony colour differences were observed for strain with and 
without Aβ42 amyloid. The appearance of pink colonies in fig: 6 
may be due loss of plasmid.  
3.2  Prion induction study with stress conditions 
Normally when stress is not applied, the yeast grows pink on YPD 
with least copper concentration while all white with 50µM CuSO4. 
But when stress is applied, the colony grows into white as well as 
pink on YPD with CuSO4. The appearance of white colonies may 
be due to aggregation of amyloid induced by stress applied. 
 
Fig 8: Aβ42 –MRF L3149 on YPD (without any stress) 
  
Fig 9: Aβ42 –MRF L3149 on YPD (with 2mM H2O2) 
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Fig 10: Aβ42 –MRF L3149 on YPD + 1µM CuSO4  
(with 2mM H2O2) 
 
Fig 11: Aβ42 –MRF L3149 on YPD (with 10mM H2O2) 
 
Fig 12: Aβ42 –MRF L3149 on YPD + 1µM CuSO4  
(with 10mM H2O2) 
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Fig 13: Aβ42 –MRF L3149 on YPD + 1µM CuSO4  
(with 12mM DTT) 
 
Fig 14: Aβ42 –MRF L3149 on YPD + 1µM CuSO4  
(with 1M NH4Ac) 
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Table 2: Amyloid Aggregation with H2O2 
 
  Stress 
Conditions 
Total no. of 
colonies 
No. of pink 
colonies 
No. of 
white 
colonies 
Percentage 
of white 
colonies 
(%) 
YPD H2O2 
(2mM) 
146 22 124 84 
YPD H2O2 
(2mM) 
156 35 121 77 
YPD + 1µM 
CuSO4 
H2O2 
(2mM) 
161 4 157 97 
YPD + 1µM 
CuSO4 
H2O2 
(2mM) 
178 9 169 94 
YPD H2O2 
(10mM) 
141 - 141 100 
YPD H2O2 
(10mM) 
167 - 167 100 
YPD + 1µM 
CuSO4 
H2O2 
(10mM) 
176 - 176 100 
YPD + 1µM 
CuSO4 
H2O2 
(10mM) 
165 - 165 100 
 
There were white colonies formed with 2mM and 10mM H2O2 
while no growth was observed when treated with 12mM DTT and 
1M NH4Ac. The latter may have been lethal to the cells hence no 
growth was observed. From Table 2, Treatment with H2O2 have 
caused aggregation of amyloid thus forming white colonies. 
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                                      Chapter 4 
Conclusion 
In this study, amyloid aggregation of Aβ42 was found when 
treated with H2O2 . The percentage of white colonies formed were 
higher with higher concentrations of H2O2. There was no growth 
or aggregation observed with DTT or NH4Ac. The Duo might 
have been lethal to the cells hence no growth of cells. 
Stress conditions are found to increase induction of [PSI +] 
formation in yeast, thus there is also a chance for its link with 
AD when exposed to various stress conditions [16].  
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